Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of PACS Group Inc (NYSE: PACS) was $39.02 for the day, up 2.39% from the previous closing price of $38.11. In other words, the price has increased by $2.39 from its previous closing price. On the day, 1.63 million shares were traded. PACS stock price reached its highest trading level at $39.1399 during the session, while it also had its lowest trading level at $37.37.
Ratios:
Our analysis of PACS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.54. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 4.19 whereas as Long-Term Debt/Eq ratio is at 3.83.
On December 17, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 24 ’25 when Dilsaver Evelyn S bought 16,724 shares for $29.90 per share. The transaction valued at 499,997 led to the insider holds 22,739 shares of the business.
MITCHELL JOHN TODD sold 159,556 shares of PACS for $4,768,379 on Nov 24 ’25. The Chief Legal Officer & Sec. now owns 755,836 shares after completing the transaction at $29.89 per share. On Nov 24 ’25, another insider, John Todd Mitchell, who serves as the Chief Legal Officer of the company, bought 159,556 shares for $27.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACS now has a Market Capitalization of 6055026176 and an Enterprise Value of 9415047168. As of this moment, PACS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.63, and their Forward P/E ratio for the next fiscal year is 19.24. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19 while its Price-to-Book (P/B) ratio in mrq is 7.01. Its current Enterprise Value per Revenue stands at 1.832 whereas that against EBITDA is 27.684.
Stock Price History:
The Beta on a monthly basis for PACS is -0.65, which has changed by 1.9069412 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, PACS has reached a high of $38.25, while it has fallen to a 52-week low of $7.50. The 50-Day Moving Average of the stock is 67.02%, while the 200-Day Moving Average is calculated to be 172.77%.
Shares Statistics:
PACS traded an average of 1.48M shares per day over the past three months and 1065750 shares per day over the past ten days. A total of 156.62M shares are outstanding, with a floating share count of 41.50M. Insiders hold about 73.50% of the company’s shares, while institutions hold 28.20% stake in the company. Shares short for PACS as of 1765756800 were 3544787 with a Short Ratio of 2.39, compared to 1763078400 on 3357277. Therefore, it implies a Short% of Shares Outstanding of 3544787 and a Short% of Float of 7.66.
